References
- Ferri C, Emdin M, Nielsen H, Bruhlmann P. Assessment of heart involvement. Chin Exp Ftheumatol 2003;21(3 suppl 29):S24–8.
- Coghlan JG, Mukerjee D. The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology. Curr Opin Ftheu-matol 2001;13:495–9.
- Alexander EL, Firestein GS, Weiss JL, Heuser RR, Leitl G, Wagner HN Jr, et al. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis. Ann Intern Med 1986;105:661–8.
- Armstrong GP, Whalley GA, Doughty RN, Gamble GD, Flett SM, Tan PL, et al. Left ventricular function in scleroderma. Br J Ftheu-matol 1996;35:983–8.
- Follansbee WP, Miller TR, Curtiss El, One JE, Bernstein FtL, Kiernan JM, et al. A controlled clinicopathologic study of myocar-dial fibrosis in systemic sclerosis (scleroderma). J Ftheumatol 1990;17:656–62.
- Sakomura Y, Nishikawa K, Kasanuki H, Nishikawa T. Myocardial involvement in rheumatic diseases (in Japanese). Nippon Ftinsho 2000;58:186–90.
- Severova EY, Guseva NG. A case of cardiac aneurysm complicating scleroderma. Cor Vasa 1963;5:230–5.